Confirmation of administrative claims-identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor alpha antagonists and disease-modifying antirheumatic drugs.

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Curtis, JR; Martin, C; Saag, KG; Patkar, NM; Kramer, J; Shatin, D; Allison, J; Braun, MM

Published Date

  • March 15, 2007

Published In

Volume / Issue

  • 57 / 2

Start / End Page

  • 343 - 346

PubMed ID

  • 17330283

Pubmed Central ID

  • 17330283

International Standard Serial Number (ISSN)

  • 0004-3591

Digital Object Identifier (DOI)

  • 10.1002/art.22544

Language

  • eng

Conference Location

  • United States